Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells

被引:85
作者
Kao S. [1 ]
Miyagi E. [1 ]
Khan M.A. [1 ]
Takeuchi H. [1 ]
Opi S. [1 ]
Goila-Gaur R. [1 ]
Strebel K. [1 ]
机构
[1] Laboratory of Molecular Microbiology, Viral Biochemistry Section, NIH, Bethesda, MD 20892-0460
关键词
Long Terminal Repeat; Arrow Head; Yellow Arrow Head; Human APOBEC3G; APOBEC3G Expression;
D O I
10.1186/1742-4690-1-27
中图分类号
学科分类号
摘要
Background: The human immunodeficiency virus Vif protein overcomes the inhibitory activity of the APOBEC3G cytidine deaminase by prohibiting its packaging into virions. Inhibition of APOBEC3G encapsidation is paralleled by a reduction of its intracellular level presumably caused by the Vif-induced proteasome-dependent degradation of APOBEC3G. Results: In this report we employed confocal microscopy to study the effects of Vif on the expression of APOBEC3G on a single cell level. HeLa cells dually transfected with Vif and APOBEC3G expression vectors revealed efficient co-expression of the two proteins. Under optimal staining conditions approximately 80% of the transfected cells scored double-positive for Vif and APOBEC3G. However, the proportion of double-positive cells observed in identical cultures varied dependent on the fixation protocol and on the choice of antibodies used ranging from as low as 40% to as high as 80% of transfected cells. Importantly, single-positive cells expressing either Vif or APOBEC3G were observed both with wild type Vif and a biologically inactive Vif variant. Thus, the lack of APOBEC3G in some Vif-expressing cells cannot be attributed to Vif-induced degradation of APOBEC3G. These findings are consistent with our results from immunoblot analyses that revealed only moderate effects of Vif on the APOBEC3G steady state levels. Of note, viruses produced under such conditions were fully infectious demonstrating that the Vif protein used in our analyses was both functional and expressed at saturating levels. Conclusions: Our results suggest that Vif and APOBEC3G can be efficiently co-expressed. Thus, depletion of APOBEC3G from Vif expressing cells as suggested previously is not a universal property of Vif and thus is not imperative for the production of infectious virions. © 2004 Kao et al; licensee BioMed Central Ltd.
引用
收藏
页数:12
相关论文
共 41 条
[1]  
Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H., Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein, Nature, 418, pp. 646-650, (2002)
[2]  
Harris R.S., Petersen-Mahrt S.K., Neuberger M.S., RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators, Mol. Cell, 10, pp. 1247-1253, (2002)
[3]  
Stopak K., de Noronha C., Yonemoto W., Greene W.C., HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability, Mol. Cell, 12, pp. 591-601, (2003)
[4]  
Kao S., Khan M.A., Miyagi E., Plishka R., Buckler-White A., Strebel K., The Human Immunodeficiency Virus Type 1 Vif Protein Reduces Intracellular Expression and Inhibits Packaging of APOBEC3G (CEM15), a Cellular Inhibitor of Virus Infectivity, J. Virol., 77, pp. 11398-11407, (2003)
[5]  
Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., Munk C., Nymark-McMahon H., Landau N.R., Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif, Cell, 114, pp. 21-31, (2003)
[6]  
Marin M., Rose K.M., Kozak S.L., Kabat D., HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation, Nat. Med., 9, pp. 1398-1403, (2003)
[7]  
Sheehy A.M., Gaddis N.C., Malim M.H., The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif, Nat. Med., 9, pp. 1404-1407, (2003)
[8]  
Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., Yu X.F., Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex, Science, 302, pp. 1056-1060, (2003)
[9]  
Liu B., Yu X., Luo K., Yu Y., Yu X.F., Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G, J. Virol., 78, pp. 2072-2081, (2004)
[10]  
Lecossier D., Bouchonnet F., Clavel F., Hance A.J., Hypermutation of HIV-1 DNA in the absence of the Vif protein, Science, 300, (2003)